Emergence of Multiple <i>EGFR</i> Extracellular Mutations during Cetuximab Treatment in Colorectal CancerSabrina Arena, Clara Montagut|Clinical Cancer Research|2015Cited by 273
Patient-Derived Xenografts and Matched Cell Lines Identify Pharmacogenomic Vulnerabilities in Colorectal CancerLuca Lazzari, Sabrina Arena|Clinical Cancer Research|2019Cited by 77
Vitamin C Restricts the Emergence of Acquired Resistance to EGFR-Targeted Therapies in Colorectal CancerAnnalisa Lorenzato, Sabrina Arena|Cancers|2020Cited by 72
Codon bias imposes a targetable limitation on KRAS-driven therapeutic resistanceMoiez Ali, Kris C. Wood, Sarah Jo Stephens et al.|Nature Communications|2017Cited by 46
Prediction of homologous recombination deficiency identifies colorectal tumors sensitive to PARP inhibitionGiorgio Corti, Sabrina Arena|npj Precision Oncology|2024Cited by 5